Select Medical (SEM) Shares Gap Up on Analyst Upgrade

Select Medical Holdings Co. (NYSE:SEM) gapped up prior to trading on Monday after Credit Suisse Group raised their price target on the stock from $18.00 to $21.00. The stock had previously closed at $21.78, but opened at $19.71. Credit Suisse Group currently has a neutral rating on the stock. Select Medical shares last traded at $19.17, with a volume of 50095 shares traded.

Other equities research analysts have also issued research reports about the stock. ValuEngine upgraded shares of Select Medical from a “hold” rating to a “buy” rating in a report on Friday, November 2nd. Zacks Investment Research upgraded shares of Select Medical from a “sell” rating to a “hold” rating in a report on Wednesday, July 11th. Four equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $20.83.

In other Select Medical news, Chairman Robert A. Ortenzio sold 11,923 shares of the stock in a transaction dated Thursday, August 30th. The shares were sold at an average price of $20.00, for a total value of $238,460.00. Following the completion of the sale, the chairman now owns 7,000,171 shares in the company, valued at approximately $140,003,420. The transaction was disclosed in a document filed with the SEC, which is available at this link. Company insiders own 19.86% of the company’s stock.

A number of large investors have recently bought and sold shares of the business. BlackRock Inc. increased its stake in Select Medical by 8.6% in the 2nd quarter. BlackRock Inc. now owns 15,243,922 shares of the health services provider’s stock valued at $276,678,000 after buying an additional 1,211,219 shares during the last quarter. Victory Capital Management Inc. increased its stake in Select Medical by 14.8% in the 3rd quarter. Victory Capital Management Inc. now owns 2,094,711 shares of the health services provider’s stock valued at $38,543,000 after buying an additional 270,498 shares during the last quarter. Schwab Charles Investment Management Inc. increased its stake in Select Medical by 6.6% in the 2nd quarter. Schwab Charles Investment Management Inc. now owns 1,055,308 shares of the health services provider’s stock valued at $19,154,000 after buying an additional 65,091 shares during the last quarter. Mesirow Financial Investment Management Equity Management purchased a new stake in Select Medical in the 3rd quarter valued at about $16,312,000. Finally, Principal Financial Group Inc. increased its stake in Select Medical by 2.3% in the 1st quarter. Principal Financial Group Inc. now owns 876,489 shares of the health services provider’s stock valued at $15,119,000 after buying an additional 19,600 shares during the last quarter. Hedge funds and other institutional investors own 75.08% of the company’s stock.

The company has a debt-to-equity ratio of 3.72, a quick ratio of 1.49 and a current ratio of 1.49. The company has a market cap of $2.67 billion, a P/E ratio of 20.71, a PEG ratio of 1.34 and a beta of 1.39.

Select Medical (NYSE:SEM) last posted its quarterly earnings data on Thursday, November 1st. The health services provider reported $0.23 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.18 by $0.05. Select Medical had a net margin of 4.32% and a return on equity of 15.95%. The firm had revenue of $1.27 billion during the quarter, compared to analyst estimates of $1.28 billion. During the same quarter last year, the business posted $0.14 EPS. The company’s revenue for the quarter was up 17.7% on a year-over-year basis. As a group, analysts expect that Select Medical Holdings Co. will post 1.05 earnings per share for the current year.

COPYRIGHT VIOLATION NOTICE: This article was originally published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this article on another domain, it was stolen and reposted in violation of international copyright and trademark laws. The original version of this article can be accessed at https://www.dispatchtribunal.com/2018/11/07/select-medical-sem-shares-gap-up-on-analyst-upgrade.html.

Select Medical Company Profile (NYSE:SEM)

Select Medical Holdings Corporation, through its subsidiary, Select Medical Corporation, operates acute care hospitals (LTCHs), inpatient rehabilitation facilities (IRFs), outpatient rehabilitation clinics, and occupational medicine centers in the United States. The company operates through four segments: Long Term Acute Care, Inpatient Rehabilitation, Outpatient Rehabilitation, and Concentra.

Further Reading: The risks of owning bonds

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply